Who owns FLXN - FLEXION THERAPEUTICS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

FLEXION THERAPEUTICS INC - COM (FLXN) Institutional Ownership

Q: What is CUSIP 33938J106?

CUSIP 33938J106 is the security identifier used in SEC filing datasets for FLXN - FLEXION THERAPEUTICS INC - COM.

CUSIP: 33938J106

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2022

Type / Class: Equity / COM
Symbol: FLXN

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 33938J106:

Q1 2022 (0 holders) Q4 2021 (0 holders) Q3 2021 (136 holders) Q2 2021 (135 holders) Q1 2021 (142 holders) Q4 2020 (136 holders) Q3 2020 (133 holders) Q2 2020 (122 holders) Q1 2020 (120 holders) Q4 2019 (130 holders)

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2022 Q1	0	$0	-$2,248,000				0
2021 Q4	0	$0	-$220,703,843	$0	$0		0
2021 Q3	37,554,915	$229,154,957	-$58,284,646	$2,206,000	$1,946,000	$6.10	136
2021 Q2	45,129,271	$371,371,813	-$18,673,690	$2,589,000	$748,000	$8.23	135
2021 Q1	46,910,587	$419,838,214	-$44,115,595	$2,496,000	$1,338,000	$8.95	142
2020 Q4	50,176,793	$579,029,742	+$4,315,089	$3,242,000	$1,132,000	$11.54	136
2020 Q3	49,712,445	$517,321,889	+$47,097,626	$2,813,000	$1,250,000	$10.41	133
2020 Q2	44,975,236	$591,401,373	+$179,273,204	$3,847,000	$2,659,000	$13.15	122
2020 Q1	31,850,134	$250,573,313	-$21,857,281	$747,000	$1,462,000	$7.87	120
2019 Q4	32,378,836	$670,230,778	-$29,441,859	$3,977,000	$15,795,000	$20.70	130
2019 Q3	34,445,576	$472,198,593	+$27,578,890	$2,197,000	$6,151,000	$13.70	123
2019 Q2	32,494,146	$399,578,492	-$18,075,119	$1,689,000	$2,494,000	$12.30	127
2019 Q1	34,068,274	$425,159,060	-$23,874,906	$1,517,000	$1,581,000	$12.48	125
2018 Q4	36,101,124	$408,708,860	-$40,591,382	$1,241,000	$2,701,000	$11.32	121
2018 Q3	38,299,532	$716,635,336	+$4,090,422	$2,145,000	$6,500,000	$18.71	128
2018 Q2	37,645,518	$972,746,740	+$28,637,569	$3,900,000	$9,469,000	$25.85	129
2018 Q1	36,748,504	$823,540,987	+$22,999,408	$4,020,000	$9,302,000	$22.41	134
2017 Q4	35,611,859	$891,731,278	+$207,638,858	$19,410,000	$17,444,000	$25.04	136
2017 Q3	27,321,036	$660,447,713	+$23,876,402	$10,905,000	$12,888,000	$24.18	116
2017 Q2	26,396,717	$532,435,669	+$50,740,549	$5,901,000	$4,307,000	$20.22	100
2017 Q1	23,485,670	$632,110,014	+$78,182,568	$6,263,000	$5,157,000	$26.91	100
2016 Q4	22,841,362	$434,273,369	+$73,974,268	$1,297,000	$3,735,000	$19.02	93
2016 Q3	18,936,450	$370,017,893	-$10,587,884	$1,436,000	$3,688,000	$19.54	84
2016 Q2	18,828,110	$281,765,448	+$82,507,085	$1,016,000	$419,000	$14.96	81
2016 Q1	13,514,310	$124,100,000	-$47,772,541	$0	$308,000	$9.20	65
2015 Q4	14,967,537	$288,410,631	-$9,894,081	$705,000	$4,137,000	$19.27	64
2015 Q3	15,855,609	$235,591,977	+$40,198,294		$4,645,000	$14.86	67
2015 Q2	13,026,563	$284,751,987	+$23,514,223			$21.89	61
2015 Q1	11,935,872	$268,760,329	+$7,141,640			$22.52	57
2014 Q4	11,767,463	$237,579,408	+$115,978,922			$20.19	44
2014 Q3	6,024,411	$110,005,544	+$1,017,751			$18.26	37
2014 Q2	6,054,774	$81,592,598	-$10,076,470			$13.48	41
2014 Q1	6,582,178	$108,274,000	+$108,274,040			$16.45	39